Continues to Hold Stake in Clovis Oncology, Inc. (NASDAQ:CLVS)

They now have a $93.00 price objective on the biopharmaceutical company's stock.

Other analysts have also issued reports about the stock.

CLVS has been the topic of a number of analyst reports. Cann assumed coverage on shares of Clovis Oncology in a research note on Thursday, June 22nd. The rating was initiated by Chardan Capital Markets with "Sell" on Tuesday, October 25. Gabelli started coverage on Clovis Oncology in a research report on Friday, July 7th. J P Morgan Chase & Co reaffirmed an "overweight" rating and issued a $111.00 target price (up from $72.00) on shares of Clovis Oncology in a report on Tuesday, June 20th. Eight research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. The stock presently has a consensus rating of Buy and an average target price of $82.47. (NASDAQ:CLVS) in a research report sent to investors on Thursday. It is now trading at $70.99 which is significantly below $87.91, the stock's 50 day moving average and well above the 200 day moving average of $66.98. The firm's market cap is $3.47 billion. The value of the total investment in Clovis Oncology, Inc. increased from $31,268,000 to $43,966,000 a change of 40.6% for the reporting period. WallachBeth Capital maintained Clovis Oncology Inc (NASDAQ:CLVS) on Wednesday, December 21 with "Hold" rating. The biopharmaceutical company reported ($1.29) EPS for the quarter, missing the consensus estimate of ($1.27) by $0.02, Briefing.com reports. The company had revenue of $14.62 million for the quarter, compared to analyst estimates of $13.07 million.

Clovis Oncology, Inc., launched on April 20, 2009, is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other worldwide markets. During the same period previous year, the business earned ($2.07) earnings per share. In the last earnings report the EPS was $-8.90 and is projected to be $-7.51 for the current year with 48,879,000 shares now outstanding. Franklin Resources Inc bolstered its holdings by buying 687,300 shares an increase of 70.3% from 03/31/2017 to 06/30/2017. If you are accessing this report on another website, it was illegally copied and republished in violation of United States & worldwide copyright & trademark legislation. The legal version of this story can be read at https://www.thestockobserver.com/2017/08/12/shell-asset-management-co-continues-to-hold-stake-in-clovis-oncology-inc-nasdaqclvs.html.

In other news, Director James C. Blair sold 18,450 shares of the business's stock in a transaction that occurred on Friday, August 4th. About 1.30 million shares traded or 30.23% up from the average. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Gillian C. Ivers-Read sold 3,000 shares of the business's stock in a transaction on Monday, July 17th. The shares were sold at an average price of $61.82, for a total value of $185,460.00. Following the completion of the sale, the insider now directly owns 203,583 shares in the company, valued at $9,647,798.37. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 27,450 shares of company stock valued at $2,052,665. Corporate insiders own 17.40% of the company's stock. LLC bought a new stake in shares of Clovis Oncology during the first quarter valued at about $4,617,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Clovis Oncology by 71.4% in the first quarter. Bank of Montreal Can now owns 2,702 shares of the biopharmaceutical company's stock worth $253,000 after buying an additional 2,000 shares during the last quarter.

Bourgeon Capital Management LLC boosted its position in shares of Clovis Oncology, Inc. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,819 shares of the biopharmaceutical company's stock valued at $116,000 after buying an additional 758 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of Clovis Oncology by 3.7% in the first quarter. Jennison Associates LLC now owns 1,185,177 shares of the biopharmaceutical company's stock valued at $110,968,000 after buying an additional 817,677 shares during the last quarter. Norges Bank bought a new stake in shares of Clovis Oncology during the fourth quarter valued at $13,155,000. 1,287,020 shares of the company's stock were exchanged.

Clovis Oncology, Inc is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other worldwide markets. The Company's fragrance products include a range of men's and women's products. Its commercial product Rucaparib is an oral, small molecule poly adenosine diphosphate (ADP)-ribose polymerase (PARP), inhibitor of PARP1, PARP2 and PARP3 approved in the United States by the Food and Drug Administration (FDA), as monotherapy for the treatment of patients with deleterious breast cancer (BRCA) (human genes associated with the fix of damaged deoxyribonucleic acid (DNA)) mutation (germline and/or somatic) associated advanced ovarian cancer, who have been treated with two or more chemotherapies, and selected for therapy based on an FDA-approved companion diagnostic for Rubraca.

Recommended News

  • Schubert, Valenzuela in United States  women's Amateur final

    Schubert, Valenzuela in United States women's Amateur final

    Wu had a 2-up lead after three holes before Stephenson evened the match with wins at No. 4 and No. 9. The dream run of 13-year-old Chia Yen Wu ended when she lost her semi-final match at the U.S.
    'Japan Could Intercept Guam-bound N. Korean Missiles'

    'Japan Could Intercept Guam-bound N. Korean Missiles'

    The island was first populated about 4,000 years ago by the ancestors of the Chamorros , still the island's largest ethnic group. Resident Isaac Camacho, 19, says he feels Guam's relationship with the USA mainland is "a little misunderstood on their part".
    VENEZUELA: Dovizioso marca la pauta en Austria

    VENEZUELA: Dovizioso marca la pauta en Austria

    El único piloto que pudo acercarse al de Cervera fue Andrea Dovizioso ( Ducati Team): se quedó a 0.144 segundos. Jorge Lorenzo ( Ducati ) y Cal Crutchlow (Honda) cerraron el Top Ten del primer ensayo.
  • Dato de inflación en EU impulsa al peso vs. dólar

    Bancomer cerró tu cotización en 18.45 pesos, Banamex en 18.25 pesos, Banorte en 18.20 pesos, mientras que Santander lo vendió en 18.16 pesos.
    Carlos Carrasco quedó cerca del juego perfecto

    Carlos Carrasco quedó cerca del juego perfecto

    El juego sin hit se le escapó a Carrasco cuando el primera base Logan Morrison le conectó sencillo cuando había dos outs en el séptimo episodio.

    "La Roca" tapa su icónico tatuaje de un toro con enorme dibujo

    Cheers to living, learning, evolving and growing. "Y a los disruptores positivos dispuestos a pegarle al universo". Un símbolo de fuerza, resistencia, corazón, poder y entrega para él y mucha gente alrededor del mundo.
  • BNP Paribas Analysts Give Volkswagen AG (VOW3) a €170.00 Price Target

    The firm's 50-day moving average price is €136.13 and its 200 day moving average price is €139.76. The stock now has a consensus rating of "Hold" and an average target price of €160.48 ($188.80).
    State teaching would-be trappers how to hunt pythons

    State teaching would-be trappers how to hunt pythons

    In January, Florida Fish and Wildlife Conservation Commission brought in Irula tribesmen to help remove the pythons. SFWMD Governing Board chairman Dan O'Keefe said the python hunt was about more than just eliminating a few pythons.
    Asestan otro golpe contra Los Cuije: detienen a ocho sicarios

    Asestan otro golpe contra Los Cuije: detienen a ocho sicarios

    Cabe recordar que que cinco de las víctimas fueron halladas calcinadas en un paraje del municipio de Cuautinchan. Lo anterior fue confirmado por fuentes extraoficiales.
  • Kasey Kahne optimistic about job prospects for 2018

    Kasey Kahne optimistic about job prospects for 2018

    Hendrick has really been supportive and making sure that ... you know, he wants me in a auto (next year)", said Kahne. Everybody seemed good and we kind of went to work like always and hope to put together a really strong weekend".
    This is the Moto X4 — Exclusive

    This is the Moto X4 — Exclusive

    On top, we can find the 5MP front-facing camera with LED flash with an aperture of f/1.7 and also an earpiece. Maybe Motorola is looking to announce the Moto Gs series in Brazil, or it maybe the Moto Z2 Force .
    La inflación porteña fue del 1,8% en julio

    La inflación porteña fue del 1,8% en julio

    La inflación de julio fue del 1,8% en la Ciudad de Buenos Aires, con lo que el aumento interanual se ubicó en el 22,9%. En el día de hoy se conocerá el índice de precios que evalúa el Instituto Nacional de Estadística y Censos.

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.